Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
50 participants
INTERVENTIONAL
2024-01-02
2027-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Dialogical Family Guidance for Neurodevelopmental Disorders
NCT04892992
A Prospective Observational Study of Family-based Interventions for Children With Neuropsychiatric and/or Psychiatric Disorders
NCT02250339
Guided Self-Help for Parents of Children With Externalizing Problem Behavior
NCT01350986
Measuring the Feasibility and Preliminary Efficacy of Therapeutic Playgroups in Early Intervention
NCT03062371
Efficacy of System Constellations in a General Population
NCT01352325
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
Group II: Families do not receive Dialogical Family Guidance (but belong to the same focus group)
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention group
These families receive Dialogical family guidance, including six meetings (during 3 months) within the intervention manual proceedings. Parents fill the questionnaires before and after the intervention.
Dialogical Family Guidance (DFG)
DFG is family intervention including six meetings with family members. The individual needs and questions of each family are discussed and issues parents bring up are seemed as important.
comparative group
These families (parents in the family) give responses how they manage in ordinary life with their child with neurodevelopmental disorders.
These families do not receive the intervention.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Dialogical Family Guidance (DFG)
DFG is family intervention including six meetings with family members. The individual needs and questions of each family are discussed and issues parents bring up are seemed as important.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* the child must be between 4-13 years.
Exclusion Criteria
* Families who are not motivated to receive DFG.
* Families who do not have a child with neurodevelopmental disorders.
4 Years
13 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tampere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Diana Cavonius-Rintahaka
PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Diana Cavonius-Rintahaka, PhD
Role: PRINCIPAL_INVESTIGATOR
Tampere University, Finland
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki university hospital
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUS/7626/2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.